Blog Entry List
NC Medicaid and the Division of Public Health (DPH) are alerting providers to the increased prevalence of syphilis in women of reproductive age; existing standards of care include testing all pregnant women at first prenatal visit, between 28-32 weeks and at delivery; and NC state law on sexually transmitted diseases.
Effective with date of service June 14, 2023, NC Medicaid covers pegunigalsidase alfa-iwxj injection, for intravenous use (Elfabrio).
Effective with date of service June 27, 2023, NC Medicaid covers glofitamab-gxbm injection, for intravenous use (Columvi)
Effective with date of service July 31, 2023, NC Medicaid covers rezafungin for injection, for intravenous use (Rezzayo)
This bulletin replaces NC Medicaid COVID-19 Vaccine and Reimbursement Guidelines for 2023-2024
Effective July 15, 2023, NC Medicaid covers beremagene geperpavec-svdt biological suspension mixed with excipient gel for topical application
Effective with date of service July 11, 2023, NC Medicaid covers efgartigimod alfa and hyaluronidase-qvfc injection
NC Medicaid will begin publishing the POS vaccine rate file in January of 2024
Effective with date of service Oct. 1, 2023, NC Medicaid covers typhoid vi polysaccharide vaccine (Typhim Vi).
Effective with date of service Oct. 1, 2023, NC Medicaid covers typhoid vaccine live oral Ty21a (Vivotif)
Effective Oct. 1, 2023, NC Medicaid covers Japanese encephalitis vaccine, inactivated, adsorbed suspension for intramuscular injection.
Effective with date of service Oct. 1, 2023, NC Medicaid covers cholera vaccine, live, oral suspension for oral administration (Vaxchora).
Effective with date of service Oct. 1, 2023, NC Medicaid covers yellow fever vaccine, for subcutaneous use (YF-Vax)
Updated toolkit available to learn who will be eligible for NC Medicaid, when and how to apply.
NC Medicaid requires prescriptions to be ordered by Medicaid enrolled providers.